Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505930 · ClinicalTrials.gov registry record · NA
Pilot HPV Vaccination in Chinese American Community
A NA study of Hpv, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT04505930: Completed NA study of Hpv, sponsored by Temple University.
NCT04505930 is a NA study of Hpv that has completed, run by Temple University. The registered enrollment target is 170 participants, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04505930, a NA study of Hpv, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.
Primary Outcome
the rate of getting HPV vaccination uptake 6 months post intervention
Conditions Studied
Interventions
- BEHAVIORAL Interventional HPV vaccination video modules
- BEHAVIORAL General Vaccination Education
Study Locations (1)
Pennsylvania
- Center for Asian Health, Lewis Katz School of Medicine, Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2015-04-27 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
What the finished NCT04505930 record still lists
NCT04505930 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Hpv appearing as the primary indexed condition, and to 2 interventions - of which Interventional HPV vaccination video modules is the first listed.
NCT04505930 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04505930 about?
NCT04505930 is a clinical study titled "Pilot HPV Vaccination in Chinese American Community". This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.
What is the current status of trial NCT04505930?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2015-04-27. Estimated completion is 2017-08-31.
What conditions does trial NCT04505930 study?
This clinical trial studies the following conditions: Hpv.
What interventions are being tested in trial NCT04505930?
The interventions under investigation include: Interventional HPV vaccination video modules (BEHAVIORAL), General Vaccination Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04505930?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04505930 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04505930's enrollment target sits among peer trials
170 14th of 24 higher than 11 of 24 other Hpv trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hpv trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI